Time is running out to secure this ASX healthcare share dividend

Investors only have until the end of trading today to get hold of the latest Virtus Health dividend.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Key points
  • Virtus Health shares are edging into the red this afternoon
  • The company's shares are due to trade ex-dividend tomorrow
  • Eligible shareholders will receive a dividend payment of 12 cents per share on 14 April

The Virtus Health Ltd (ASX: VRT) share price is seesawing today. It has been down as low as $8.21 and as high as $8.27 but it is currently 0.12% in the red at $8.22.

This comes despite the fertility treatment company not releasing any price-sensitive announcements to the ASX today.

In comparison, the All Ordinaries Index (ASX: XAO) has shot up 1.17% to 7,647.6 points today.

So what's been happening with Virtus Health?

A man points at a paper as he holds an alarm clock, indicating the ex-dividend date is approaching.

Image source: Getty Images

Virtus Health shares set to go ex-dividend

Today is the last chance for investors to get their hands on the Virtus Health interim dividend.

Investors need to buy Virtus Health shares before market close today to be eligible for the interim dividend. The ex-dividend date is tomorrow, Wednesday 23 March.

It is worth noting that on the ex-dividend day, the share price traditionally falls in proportion to the dividend amount. This is because investors tend to sell off the company's shares after securing the dividend.

What does this mean for Virtus Health shareholders?

For those who are eligible for the Virtus Health interim dividend, shareholders will receive a payment of 12 cents per share on 14 April.

The dividend is also fully franked, which means shareholders can expect to receive tax credits from this.

Virtus Health share price summary

When looking at the past 12 months, the Virtus Health share price is up almost 40%. It is also up 20% this year to date.

The company's shares reached a 52-week high of $8.33 a little over a week ago. This came after the company announced it had signed a transaction implementation deed with an entity controlled by CapVest Partners. Under the deed, CapVest will acquire 100% of Virtus shares by a scheme of arrangement. 

Based on today's price, Virtus Health commands a market capitalisation of roughly $703.97 million and has a trailing dividend yield of 2.92%.

Motley Fool contributor Aaron Teboneras has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Healthcare Shares

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Orthocell caps 26% surge this week with first US Military Surgery

The company's commercial rollout is off to a good start.

Read more »

Medical workers examine an x-ray or scan in a hospital laboratory.
Healthcare Shares

This ASX health tech stock just hit a new record high. Could it go even higher?

Morgans believes there's still upside to be had.

Read more »

Female scientist working in a laboratory.
Healthcare Shares

Down almost 20% this year, how high could Mesoblast shares go?

The forward pipeline is looking promising.

Read more »

Three health professionals at a hospital smile for the camera.
Healthcare Shares

Down 38% this year, is it finally time to buy low on CSL, ResMed and Pro Medicus shares?

These three stocks might be too cheap to ignore.

Read more »

Modern accountant woman in a light business suit in modern green office with documents and laptop.
Healthcare Shares

How much would $10,000 become if CSL shares returned to their record high?

After a sharp decline, CSL is in a new phase. The question is what happens next.

Read more »

A man clenches his fists with glee having seen the share price go up on the computer screen in front of him.
Healthcare Shares

Why this ASX biotech stock just rocketed 89% today

Immutep shares rocket after a fresh FDA win

Read more »

Two lab workers fist pump each other.
Healthcare Shares

Orthocell shares soar 22% on landmark US breakthrough

The company has been given approval to sell Remplir in more than 220 hospitals in the US.

Read more »

Shot of a scientist using a computer while conducting research in a laboratory.
Healthcare Shares

This ASX biotech stock just jumped again as its lead drug trial moves ahead

The latest trial milestone sends this ASX biotech stock higher today.

Read more »